21 May 2013
Keywords: sanofi, halts, ketek, trials, children, french, drug
Article | 19 June 2006
French drug major Sanofi-Aventis has suspended pediatric trials of its antibiotic Ketek (telithromycin), reports the Wall Street Journal. A
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 June 2006
12 June 2006
20 May 2013
© 2013 thepharmaletter.com